SAN DIEGO — Singular Genomics Systems, Inc. today announced the appointment of John Stark as Chief Executive Officer. This leadership transition comes as Singular builds on the launch of its market-leading spatial platform and enters its next phase, focused on expanding adoption, deepening strategic partnerships, and increasing the impact of multimodal spatial data across translational research, drug development, and future […]
Amsbio has expanded its range of iPSC Differentiation Kits that provide fast and flexible generation of specific cell types without sacrificing cell purity. New to market – Quick-Glia™ product line consist of human induced pluripotent stem cell derived glial cells designed for rapid, reliable, and reproducible research in neurobiology, drug discovery, and neurodegeneration. Offering a reproducible, and scalable solution, these […]
Luxembourg/New York/Paris – Astorg, a leading pan-European private equity firm, announces that it has signed a definitive agreement to acquire the microbiology business from Thermo Fisher Scientific (or “the Company”). Through the transaction, Thermo Fisher’s microbiology business will become an independent, privately owned platform, backed by Astorg. Building on its deep healthcare sector expertise and […]
WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has signed a definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides […]
ArgusEye, a provider of advanced sensor solutions for real-time monitoring and control of bioprocesses, today announced the closing of a €3.3M funding round. The round includes continued support from existing investors, Voima Ventures and Eir Ventures, along with new investor Impilo Partners Invest. The funding will accelerate the continued development of ArgusEye’s Auga™ platform, a […]
SHANGHAI — Shanghai BioEngine Sci-tech Co., Ltd. announced the launch of UltraFeed, a next-generation fed-batch supplement designed to elevate CHO cell productivity in monoclonal antibody, bispecific, and recombinant protein manufacturing. Across diverse cell lines and molecule formats, UltraFeed delivers an average titer increase of 25%, with select programs achieving gains as high as 48% when compared to alternative feed […]
RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Ludovic Brellier will join the company as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer on May 1, 2026. In this role, […]
ATLANTA, GA — Axion BioSystems, Inc., a leading provider of live-cell analysis technologies, today announced that Agilent Technologies, Inc. and Axion BioSystems have fully resolved the issues in the two lawsuits between them, pending in the United States District Court for the District of Delaware, pursuant to the terms of a confidential settlement agreement. Neither […]
VANCOUVER, British Columbia — ViewsML, a company building the computational layer for biomarker discovery by transforming tissue analysis from a lab process into software, today announced the completion of an oversubscribed $4.9M seed funding round led by Wittington Ventures. Additionally, new investors Continuum Health Ventures and Mayo Clinic contributed alongside repeat investors RiSC Capital, Debiopharm, […]
The Launch Early Access Program (LEAP) from Leica Microsystems provides supported access to the ATTOAuriga reagent platform Wetzlar, Germany – Leica Microsystems, a Danaher company and a leading provider of microscopy and scientific solutions, announced today that its Launch Early Access Program (LEAP) is now available, offering supported early access to ATTOAuriga, a novel spatial […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
